PLAINSBORO, N.J., Oct. 27, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences
Holdings Corporation (Nasdaq:IART), a world leader in regenerative medicine,
announced today that it has made Forbes magazine's 2009 list of "200 Best Small
Companies."
"We're honored to have been named to Forbes 200 Best Small Companies for the
fifth time in our history," said Stuart Essig, Integra's President and CEO. "Our
success is due to the dedication of our employees who, since Integra's founding
20 years ago, have helped the company grow into a leader in developing medical
devices, particularly for neurosurgery, spinal surgery and extremity
reconstruction. We also have one of the largest surgical instrument companies in
the United States. We look forward to continuing to grow our business and
provide life-saving devices for patients around the world."
The Forbes 200 Best Small Companies ranking is limited to companies with sales
between $5 million and $750 million and a stock price no lower than $5. A
company's ranking is based on return on equity, sales growth, and profit growth
over the past 12 months and over five years. Forbes also compares a company's
stock performance with that of its industry peers.
Integra LifeSciences Holdings Corporation, a world leader in regenerative
medicine, is a global medical device company dedicated to improving the quality
of life for millions of patients each year. The company's products are used
primarily in orthopedics, neurosurgery and general surgery. Headquartered in
Plainsboro, New Jersey, Integra has research and manufacturing facilities
throughout the world.
IART-G
-0-
CONTACT: Integra LifeSciences Holdings Corporation
Gianna Sabella, Director of Corporate Communications
(609) 936-2389
gsabella@integra-LS.com
